Retinal ganglion cells in diabetes

Diabetic retinopathy has long been recognized as a vascular disease that develops in most patients, and it was believed that the visual dysfunction that develops in some diabetics was due to the vascular lesions used to characterize the disease. It is becoming increasingly clear that neuronal cells of the retina also are affected by diabetes, resulting in dysfunction and even degeneration of some neuronal cells. Retinal ganglion cells (RGCs) are the best studied of the retinal neurons with respect to the effect of diabetes. Although investigations are providing new information about RGCs in diabetes, including therapies to inhibit the neurodegeneration, critical information about the function, anatomy and response properties of these cells is yet needed to understand the relationship between RGC changes and visual dysfunction in diabetes.

[1]  Allen R Kunselman,et al.  Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice. , 2008, Investigative ophthalmology & visual science.

[2]  G. Liou,et al.  Peroxynitrite Mediates Retinal Neurodegeneration by Inhibiting Nerve Growth Factor Survival Signaling in Experimental and Human Diabetes , 2008, Diabetes.

[3]  T. Oshitari,et al.  Mitochondria- and caspase-dependent cell death pathway involved in neuronal degeneration in diabetic retinopathy , 2008, British Journal of Ophthalmology.

[4]  Wei Dai,et al.  Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. , 2008, Investigative ophthalmology & visual science.

[5]  N. Tanimoto,et al.  Early electroretinographic features of streptozotocin‐induced diabetic retinopathy , 2007, Clinical & experimental ophthalmology.

[6]  J. Kusari,et al.  Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats. , 2007, Investigative ophthalmology & visual science.

[7]  T. Kern,et al.  Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes , 2007, Diabetologia.

[8]  S. Thanos,et al.  Pathological changes in human retinal ganglion cells associated with diabetic and hypertensive retinopathy , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[9]  L. Missotten,et al.  Expression of antiapoptotic and proapoptotic molecules in diabetic retinas , 2007, Eye.

[10]  T. Kern,et al.  Salicylate-Based Anti-Inflammatory Drugs Inhibit the Early Lesion of Diabetic Retinopathy , 2007, Diabetes.

[11]  S. Mohr,et al.  Topical Administration of Nepafenac Inhibits Diabetes-Induced Retinal Microvascular Disease and Underlying Abnormalities of Retinal Metabolism and Physiology , 2007, Diabetes.

[12]  N. Osborne,et al.  Oscillatory potentials and the b-Wave: Partial masking and interdependence in dark adaptation and diabetes in the rat , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[13]  S. Mohr,et al.  Inhibition of Caspase-1/Interleukin-1β Signaling Prevents Degeneration of Retinal Capillaries in Diabetes and Galactosemia , 2007, Diabetes.

[14]  H. Qian,et al.  An electrophysiological study of retinal function in the diabetic female rat. , 2006, Investigative ophthalmology & visual science.

[15]  A. Vingrys,et al.  Rod photoreceptor dysfunction in diabetes: activation, deactivation, and dark adaptation. , 2006, Investigative ophthalmology & visual science.

[16]  A. Barber,et al.  Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas. , 2006, Investigative ophthalmology & visual science.

[17]  Masaki Tanito,et al.  Diabetes-associated retinal nerve fiber damage evaluated with scanning laser polarimetry. , 2006, American journal of ophthalmology.

[18]  G. Seigel,et al.  Systemic IGF-I treatment inhibits cell death in diabetic rat retina. , 2006, Journal of diabetes and its complications.

[19]  Gezhi Xu,et al.  Dendritic Abnormalities in Retinal Ganglion Cells of Three-Month Diabetic Rats , 2006, Current eye research.

[20]  D. Chen,et al.  Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. , 2005, Investigative ophthalmology & visual science.

[21]  S. Chung,et al.  Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. , 2005, Diabetes.

[22]  A. Schmidt,et al.  The RAGE axis in early diabetic retinopathy. , 2005, Investigative ophthalmology & visual science.

[23]  T. Gardner,et al.  The Ins2Akita mouse as a model of early retinal complications in diabetes. , 2005, Investigative ophthalmology & visual science.

[24]  Y. Khalifa,et al.  Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. , 2005, The American journal of pathology.

[25]  T. Gardner,et al.  Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. , 2005, Diabetes.

[26]  M. Bartoli,et al.  Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration , 2005, Journal of Cell Science.

[27]  V. Ganapathy,et al.  Death of retinal neurons in streptozotocin-induced diabetic mice. , 2004, Investigative ophthalmology & visual science.

[28]  H. Nawa,et al.  Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells. , 2004, Diabetes.

[29]  Luc Missotten,et al.  Expression of apoptosis markers in the retinas of human subjects with diabetes. , 2004, Investigative ophthalmology & visual science.

[30]  W. Hare,et al.  Origins of the electroretinogram oscillatory potentials in the rabbit retina , 2004, Visual Neuroscience.

[31]  S. Mohr,et al.  Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Müller cells. , 2004 .

[32]  T. Kraft,et al.  Oscillatory potential analysis and ERGs of normal and diabetic rats. , 2004, Investigative ophthalmology & visual science.

[33]  R. Caldwell,et al.  Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite. , 2003, The American journal of pathology.

[34]  M. Chun,et al.  Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina , 2003, Diabetologia.

[35]  C. Gerhardinger,et al.  A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. , 2003, Diabetes.

[36]  S. Ozdek,et al.  Assessment of nerve fiber layer in diabetic patients with scanning laser polarimetry , 2002, Eye.

[37]  K. Oyanagi,et al.  Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin‐diabetic rats , 2002, Neuropathology : official journal of the Japanese Society of Neuropathology.

[38]  D. Puro,et al.  Diabetes-induced dysfunction of the glutamate transporter in retinal Müller cells. , 2002, Investigative ophthalmology & visual science.

[39]  V. P. Costa,et al.  Retinal nerve fibre layer loss in patients with type 1 diabetes mellitus without retinopathy , 2002, The British journal of ophthalmology.

[40]  I. Perlman,et al.  Early retinal damage in experimental diabetes: electroretinographical and morphological observations. , 2002, Experimental eye research.

[41]  S. Mohr,et al.  Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. , 2002, Diabetes.

[42]  R. Kowluru,et al.  Diabetes-induced Activation of Caspase-3 in Retina: Effect of Antioxidant Therapy , 2002, Free radical research.

[43]  C. C. Bailey,et al.  Visual symptomatology in patients with sight‐threatening diabetic retinopathy , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[44]  A. Barber,et al.  Abnormal centrifugal axons in streptozotocin-diabetic rat retinas. , 2001, Investigative ophthalmology & visual science.

[45]  T. Hirose,et al.  Neurovisual abnormalities preceding the retinopathy in patients with long-term type 1 diabetes mellitus , 2001, Graefe's Archive for Clinical and Experimental Ophthalmology.

[46]  T. Kern,et al.  Retinal glutamate in diabetes and effect of antioxidants , 2001, Neurochemistry International.

[47]  M. Ino-ue,et al.  Polyol metabolism of retrograde axonal transport in diabetic rat large optic nerve fiber. , 2000, Investigative ophthalmology & visual science.

[48]  N. Chaturvedi Modulation of the renin-angiotensin system and retinopathy , 2000, Heart.

[49]  E. Ling,et al.  Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats , 2000, Visual Neuroscience.

[50]  T. Gardner,et al.  Retinal neurodegeneration: early pathology in diabetes , 2000, Clinical & experimental ophthalmology.

[51]  G B Arden,et al.  The electroretinogram in diabetic retinopathy. , 1999, Survey of ophthalmology.

[52]  M. Inoue,et al.  Alterations in retrograde axonal transport in optic nerve of type I and type II diabetic rats. , 1998, The Kobe journal of medical sciences.

[53]  L. Wachtmeister,et al.  Oscillatory potentials in the retina: what do they reveal , 1998, Progress in Retinal and Eye Research.

[54]  Philip D. Harvey,et al.  Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 , 1998, BMJ.

[55]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[56]  R. Holman,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .

[57]  T. Gardner,et al.  Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. , 1998, The Journal of clinical investigation.

[58]  M. Ino-ue,et al.  Effect of aminoguanidine on optic nerve involvement in experimental diabetic rats , 1998, Brain Research.

[59]  E. Chihara,et al.  [Analysis of diabetic optic neuropathy with a topographic laser scanning system]. , 1998, Nippon Ganka Gakkai zasshi.

[60]  A. Barber,et al.  Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. , 1998, Diabetes.

[61]  H. Kuriyama,et al.  Structural impairments in optic nerve of diabetic rats ameliorated with the aldose reductase inhibitor. , 1998, Experimental eye research.

[62]  Kazuo Kawasaki,et al.  Electrical responses from diabetic retina , 1998, Progress in Retinal and Eye Research.

[63]  A. Sjølie,et al.  Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes , 1998, The Lancet.

[64]  E. Guillet,et al.  Elevated γ-Aminobutyric Acid, Glutamate, and Vascular Endothelial Growth Factor Levels in the Vitreous of Patients With Proliferative Diabetic Retinopathy , 1997 .

[65]  D. Zack,et al.  TUNEL-positive ganglion cells in human primary open-angle glaucoma. , 1997, Archives of ophthalmology.

[66]  H. Hammes,et al.  Nerve Growth Factor Prevents Both Neuroretinal Programmed Cell Death and Capillary Pathology in Experimental Diabetes , 1995, Molecular medicine.

[67]  A. Sima,et al.  The preventive effect of aldose reductase inhibition on diabetic optic neuropathy in the BB/W-rat , 1993, Diabetologia.

[68]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[69]  E. Chihara,et al.  Retinal nerve fiber layer defect as an early manifestation of diabetic retinopathy. , 1993, Ophthalmology.

[70]  A. Sima,et al.  Impaired visual evoked potential and primary axonopathy of the optic nerve in the diabetic BB/W-rat , 1992, Diabetologia.

[71]  G. Kieselbach,et al.  Electrophysiological changes in juvenile diabetics without retinopathy. , 1990, Archives of ophthalmology.

[72]  T. Kern,et al.  Progression of Incipient Diabetic Retinopathy During Good Glycemic Control , 1987, Diabetes.

[73]  T. Scott,et al.  Vascular and neural changes in the rat optic nerve following induction of diabetes with streptozotocin. , 1986, Journal of anatomy.

[74]  A J Wilkins,et al.  Impaired contrast sensitivity in diabetic patients with and without retinopathy: a new technique for rapid assessment. , 1985, The British journal of ophthalmology.

[75]  S E Simonsen,et al.  THE VALUE OF THE OSCILLATORY POTENTIAL IN SELECTING JUVENILE DIABETICS AT RISK OF DEVELOPING PROLIFERATIVE RETINOPATHY , 1980, Metabolic and pediatric ophthalmology.

[76]  E. Reed,et al.  Neuro-optic cell apoptosis and microangiopathy in KKAY mouse retina. , 2004, International journal of molecular medicine.

[77]  D. Puro Diabetes-induced dysfunction of retinal Müller cells. , 2002, Transactions of the American Ophthalmological Society.

[78]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[79]  K. Dong,et al.  Retrograde axonal transport impairment of large- and medium-sized retinal ganglion cells in diabetic rat. , 2000, Current eye research.

[80]  E. Guillet,et al.  Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. , 1997, Archives of ophthalmology.

[81]  K. Kawasaki,et al.  Development of electroretinographic alterations in streptozotocin-induced diabetes in rats. , 1995, Ophthalmic research.

[82]  A. Moskowitz,et al.  Contrast sensitivity in diabetics with and without background retinopathy. , 1985, Archives of ophthalmology.